In this study the 
Introduction
Drugs that reduce eicosanoid synthesis might be valuable in symptomatic and curative therapy of various inflammatory diseases. Such drugs include cAMP elevating compounds like the xanthine derivatives theophylline and IBMX, and sympaticomimetic drugs and inhibitors of cyclic nucleotide phosphodiesterase isoenzymes. 1'2 Milrinone and sulmazole are two recently developed cardiotonic and vasodilator drugs that belong to the latter category. '4 In previous experiments we compared the effects of milrinone, sulmazole and theophylline in the rat isolated lung. We showed that these drugs inhibited antigen induced bronchoconstriction, vasoconstriction and SRS-A release, leaving the release of the preformed mediators histamine and serotonin unaffected. Rossing et al. also showed a bronchorelaxant effect of milrinone against a variety of agonists in trachea, lung parenchyma and pulmonary artery, that could be counteracted by indomethacin. 6 This led them to hypothesize that milrinone exerted a differential effect on arachidonic acid metabolism and either induced the synthesis of bronchorelaxing prostaglandins or reduced indomethacin enhanced production of bronchoconstrictive leukotrienes. In this study we addressed the question of whether cAMP mediated drugs induce a differential reduction of branches of the arachidonic acid metabolism rather (C) (Fig. ld) .
The bronchoconstrictive prostaglandin PGF2 and the stabile metabolite of thromboxane A2, TXB2, were released in equal amounts (-+-1 000 pg min -) (Fig. l e) . The Table 2 Data are expressed as percentage inhibition of control data of bronchoconstriction and histamine release as given in Table 1, and represent means _+ SEM, n 6 for all (the SEM is calculated from the variances of both the control and the treated values).
The asterisks indicate significance of difference with controls at p < 0.05 or, if double, at p < 0.01. AUC: area under curve' HR" histamine release; ND" not determined. 22 The selectivity of this agent obviously needs further documentation.
Antigen induced production of leukotrienes and other eicosanoids is probably not directly responsible for early antigen induced bronchoconstriction. The drugs tested in this study reduced bronchoconstriction at concentrations that were inadequate for inhibition of leukotriene production. A similar observation has been made for forskolin. 23 In view of these data, our finding that AA 861 had no effect on bronchoconstriction, while almost abolishing leukotriene production, supports the prevailing notion that leukotrienes have little significance in early anaphylactic bronchoconstriction in the rat. 24, 25 In conclusion, all cAMP mediated drugs reduced antigen induced bronchoconstriction and the production of eicosanoids in isolated rat lungs. Arachidonic acid metabolism is impeded at a site proximal to the separation into lipoxygenase and cyclooxygenase pathways. Whether 
